|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3700 AUD | 0.00% |
|
-1.33% | -43.08% |
| 07-29 | Recce Pharmaceuticals in Position to Benefit from US ASPR Medical Countermeasures Strategy | MT |
| 07-21 | Recce Pharmaceuticals Reports Higher Cash Balance in June Quarter | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 77.78M | - | ||||
| 1,024B | |||||
| 618B | |||||
| 443B | |||||
| 349B | |||||
| 297B |
Select your edition
All financial news and data tailored to specific country editions
